Type 2 diabetes mellitus (T2D) is a chronic metabolic disease resulting from insulin
resistance and progressively reduced insulin secretion, which leads to impaired glucose …

Historically, the focus of type II diabetes mellitus (T2DM) research has been on host
metabolism and hormone action. However, emerging evidence suggests that the gut …

Genetic variation in holobionts (host and microbiome), occurring in both host and
microbiome genomes, can be observed from two perspectives: observable variations and …

To develop a more effective and safer drug for the treatment of type 2 diabetes mellitus
(T2DM), polysaccharides-based hydrogel microparticles as oral insulin delivery was …

Bioinformatics is inherently an innovative field that is situated at the limit of life and computer
sciences that allowed new technological advances in genome sequencing, data processing …

Abstract Type 2 diabetes (T2D) is the fastest growing non-infectious disease worldwide.
Impaired insulin secretion from pancreatic beta-cells is a hallmark of T2D, but the …

Monogenic diabetes is caused by one or even more genetic variations, which may be
uncommon yet have a significant influence and cause diabetes at an early age. Monogenic …

Type 2 diabetes mellitus (T2DM) is one of the world's leading causes of death and life-
threatening conditions. Therefore, we review the complex vicious circle of causes …

Diabetes mellitus, commonly referred to as diabetes, is a combination of many metabolic
diseases. Insulin deficiency in our body is the main cause of diabetes. Insulin is one of the …

Aim Hyperglycaemia diagnosed in pregnancy (HiP) is a serious and frequent complication
of pregnancy, increasing the risk for adverse maternal and neonatal outcomes. Investigate …